BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.68% |
| 2 | Consumer Discretionary | 5.92% |
| 3 | Healthcare | 5.84% |
| 4 | Financials | 5.12% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELOX
3801
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $5.76K | ﹤0.01% |
48
-147
| -75% | -$16.6K |
|
3802
Sasol
SSL
$7.17B
| $5.76K | ﹤0.01% |
747
-56
| -7% | -$306 |
|
3803
FS Bancorp
FSBW
$326M
| $5.75K | ﹤0.01% |
298
-2,206
| -88% | -$43K |
|
|
AAIC
3804
DELISTED
Arlington Asset Investment Corp.
AAIC
| $5.74K | ﹤0.01% |
1,934
-9,171
| -83% | -$24.5K |
|
3805
Lexicon Pharmaceuticals
LXRX
$1.04B
| $5.73K | ﹤0.01% |
2,874
-10,846
| -79% | -$21.3K |
|
3806
Main Street Capital
MAIN
$5.54B
| $5.73K | ﹤0.01% |
184
| – | – |
|
3807
Radiant Logistics
RLGT
$406M
| $5.72K | ﹤0.01% |
1,456
-10,693
| -88% | -$41.2K |
|
|
SFE
3808
DELISTED
Safeguard Scientifics, Inc.
SFE
| $5.7K | ﹤0.01% |
814
-5,247
| -87% | -$33.2K |
|
3809
CorMedix
CRMD
$639M
| $5.69K | ﹤0.01% |
903
-6,978
| -89% | -$32.3K |
|
3810
Franklin Financial Services
FRAF
$289M
| $5.65K | ﹤0.01% |
218
-1,061
| -83% | -$27.4K |
|
3811
X4 Pharmaceuticals
XFOR
$425M
| $5.64K | ﹤0.01% |
20
-135
| -87% | -$37K |
|
|
KZR
3812
DELISTED
Kezar Life Sciences
KZR
| $5.64K | ﹤0.01% |
109
-806
| -88% | -$40.7K |
|
|
TYME
3813
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $5.63K | ﹤0.01% |
4,234
-14,656
| -78% | -$20K |
|
3814
BayCom
BCML
$339M
| $5.63K | ﹤0.01% |
436
-2,910
| -87% | -$36K |
|
3815
NI Holdings
NODK
$313M
| $5.6K | ﹤0.01% |
379
-2,614
| -87% | -$35.5K |
|
3816
Smith Micro Software
SMSI
$16.2M
| $5.59K | ﹤0.01% |
+31
| New | +$5.61K |
|
|
FPRX
3817
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $5.58K | ﹤0.01% |
914
-9,692
| -91% | -$39.9K |
|
3818
British American Tobacco
BTI
$124B
| $5.55K | ﹤0.01% |
143
+123
| +615% | +$4.71K |
|
3819
INNOVATE Corp
VATE
$102M
| $5.53K | ﹤0.01% |
166
+155
| +1,409% | +$4.38K |
|
|
CMRX
3820
DELISTED
Chimerix, Inc.
CMRX
| $5.52K | ﹤0.01% |
1,780
-13,151
| -88% | -$34K |
|
3821
Donegal Group Class A
DGICA
$696M
| $5.52K | ﹤0.01% |
388
-2,822
| -88% | -$40.3K |
|
3822
Mistras Group
MG
$584M
| $5.49K | ﹤0.01% |
1,390
-4,618
| -77% | -$19.1K |
|
3823
ProShares UltraShort Utilities
SDP
$4.19M
| $5.47K | ﹤0.01% |
+55
| New | +$5.53K |
|
3824
Capital Bancorp
CBNK
$616M
| $5.45K | ﹤0.01% |
509
-1,986
| -80% | -$21.5K |
|
3825
Norwood Financial Corp
NWFL
$376M
| $5.43K | ﹤0.01% |
219
-1,595
| -88% | -$37.8K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.